Teoxane Laboratories, the Swiss pioneer in æsthetic medicine, renowned for its cutting-edge dermal fillers and advanced skin care innovations, is proud to announce the US launch of its dermocosmetics line. With a steadfast commitment to scientific rigour, product excellence, and innovative technology, Teoxane is bringing its globally acclaimed skin care solutions to US consumers. Teoxane’s dermocosmetics line will be available in clinics throughout the US.
Founded in 2003 by Valérie Taupin, Teoxane has redefined the æsthetics industry with its unparalleled expertise in hyaluronic acid. As a global leader in æsthetic medicine, Teoxane is celebrated for its mastery in developing dermal fillers and topical solutions.
Introducing RHA: the next frontier in hyaluronic acid
At the heart of Teoxane’s skin care solutions lies its proprietary RHA (resilient hyaluronic acid) technology. This advanced formulation delivers optimal hydration, skin barrier protection, and visible smoothing. Key benefits include:
• superior hydration: RHA increases hydration by 7 per cent more than traditional linear hyaluronic acid;
• skin barrier protection: reduces trans-epidermal water loss (TEWL) by 27 per cent, strengthening the skin’s natural defence;
• visible results: clinical trials show a noticeable reduction in the appearance of primary lines, resulting in visibly smoother skin.
The dermocosmetics line, developed in collaboration with health care professionals, is designed to address key skin concerns, including hydration, appearances of wrinkles, appearance of uneven pigmentation, and skin texture.
For 20 years, Teoxane has pushed innovation, pioneered the future of æsthetics and opened the door to a new world of natural, expressive, and emotive beauty. The company was founded on a singular vision: to unlock the possibilities of æsthetic treatments through high-performance dermal filler and dermocosmetics, rooted in rigorous scientific research. Visit www.teoxane.us for more information.